
Gathering preclinical pace: cellular immunotherapy against solid tumours
Two recently published studies provide preclinical insights into ‘training’ CAR T cells that may potentially lead to more effective and less toxic immunotherapy approaches
Two recently published studies provide preclinical insights into ‘training’ CAR T cells that may potentially lead to more effective and less toxic immunotherapy approaches
Many studies presented at ESMO Congress 2022 show the potential of artificial intelligence to enhance personalised oncology
Recent evidence suggests a role of the microbiome in cancer pathogenesis and as a potential therapeutic target, but it is still early days
The new FDA guidance could be an important step toward necessary change to give adequate representation of older adults in cancer clinical trials
A virtual space where to discuss the latest achievements in precision oncology — Authored by Elena Garralda.
A virtual space where to discuss the latest achievements in precision oncology - Authored by Elena Garralda.
A virtual space where to discuss the latest achievements in precision oncology - Authored by Elena Garralda.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.